| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.06 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.052 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.054 | 0.8 |